6LEGRAND E. Aceclofenac in the mangementn of inflannnatory pain [ J ]. Expert Opin Pharmacothe, 2004,5 ( 6 ) : 1347 - 1357.
7LUDWING C, BRINKMEIER T, FROSH PJ. Exudative erythema muhiforme with transition to a toxic epidermal necrolysis after tak- ing aceclofenac ( Beofenac ) [ J ]. Dtsch Med Wochenschr, 2003,128.
8American College of Rheumatology Ad Hoe Group on use of selec- tive and nonselective nonsteroidal antiinflammatory drugs. Recom- mendations for use of selective and nonselective nonsteroidal anti- inflammatory drugs: an American College of Rheumatology white paper[J]. Arthritis Rheum, 2008, 59(8) : 1058 - 1073.
9Schattenkirchner M,Milachowski KA.A double-blind,multieen-tre,randomised clinical trial comparing tIIe efficacy and tolcrabil-ity of aceclofenac with dielofenac resinate in patients with acute low backpain[J].Clin Rheumatol,2003,22(2):127-35.
10Pefis F,Bird H A,Semi U,et a1.Treatment compliance and safety of aeeclofenac veius standard NSAIDs in patients with common arthritic disorders:a meta-analysis[J].Eur J Rheumatol Inflamm,1996,6(1):37-45.
